Uni Oxford begin Phase II/III vaccine clinical trial

University of Oxford researchers have begun recruiting for the next phase in human trials of a COVID-19 vaccine 10,260 adults and children at partner institutions across the country.

Adult participants in both the Phase II and Phase III groups will be randomised to receive one or two doses of either the ChAdOx1 nCoV-19 vaccine or a licensed vaccine (MenACWY) that will be used as a ‘control’ for comparison.